2021 DORIS definition of remission in SLE: final recommendations from an international task force
ObjectiveTo achieve consensus on a definition of remission in SLE (DORIS).BackgroundRemission is the stated goal for both patient and caregiver, but consensus on a definition of remission has been lacking. Previously, an international task force consisting of patient representatives and medical spec...
Saved in:
| Published in | Lupus science & medicine Vol. 8; no. 1; p. e000538 |
|---|---|
| Main Authors | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
England
Lupus Foundation of America
01.11.2021
BMJ Publishing Group LTD BMJ Publishing Group |
| Series | Original research |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | ObjectiveTo achieve consensus on a definition of remission in SLE (DORIS).BackgroundRemission is the stated goal for both patient and caregiver, but consensus on a definition of remission has been lacking. Previously, an international task force consisting of patient representatives and medical specialists published a framework for such a definition, without reaching a final recommendation.MethodsSeveral systematic literature reviews were performed and specific research questions examined in suitably chosen data sets. The findings were discussed, reformulated as recommendations and voted on.ResultsBased on data from the literature and several SLE-specific data sets, a set of recommendations was endorsed. Ultimately, the DORIS Task Force recommended a single definition of remission in SLE, based on clinical systemic lupus erythematosus disease activitiy index (SLEDAI)=0, Evaluator’s Global Assessment <0.5 (0–3), prednisolone 5 mg/day or less, and stable antimalarials, immunosuppressives, and biologics.ConclusionThe 2021 DORIS definition of remission in SLE is recommended for use in clinical care, education, and research including clinical trials and observational studies. |
|---|---|
| AbstractList | ObjectiveTo achieve consensus on a definition of remission in SLE (DORIS).BackgroundRemission is the stated goal for both patient and caregiver, but consensus on a definition of remission has been lacking. Previously, an international task force consisting of patient representatives and medical specialists published a framework for such a definition, without reaching a final recommendation.MethodsSeveral systematic literature reviews were performed and specific research questions examined in suitably chosen data sets. The findings were discussed, reformulated as recommendations and voted on.ResultsBased on data from the literature and several SLE-specific data sets, a set of recommendations was endorsed. Ultimately, the DORIS Task Force recommended a single definition of remission in SLE, based on clinical systemic lupus erythematosus disease activitiy index (SLEDAI)=0, Evaluator’s Global Assessment <0.5 (0–3), prednisolone 5 mg/day or less, and stable antimalarials, immunosuppressives, and biologics.ConclusionThe 2021 DORIS definition of remission in SLE is recommended for use in clinical care, education, and research including clinical trials and observational studies. To achieve consensus on a definition of remission in SLE (DORIS). Remission is the stated goal for both patient and caregiver, but consensus on a definition of remission has been lacking. Previously, an international task force consisting of patient representatives and medical specialists published a framework for such a definition, without reaching a final recommendation. Several systematic literature reviews were performed and specific research questions examined in suitably chosen data sets. The findings were discussed, reformulated as recommendations and voted on. Based on data from the literature and several SLE-specific data sets, a set of recommendations was endorsed. Ultimately, the DORIS Task Force recommended a single definition of remission in SLE, based on clinical systemic lupus erythematosus disease activitiy index (SLEDAI)=0, Evaluator's Global Assessment <0.5 (0-3), prednisolone 5 mg/day or less, and stable antimalarials, immunosuppressives, and biologics. The 2021 DORIS definition of remission in SLE is recommended for use in clinical care, education, and research including clinical trials and observational studies. To achieve consensus on a definition of remission in SLE (DORIS).OBJECTIVETo achieve consensus on a definition of remission in SLE (DORIS).Remission is the stated goal for both patient and caregiver, but consensus on a definition of remission has been lacking. Previously, an international task force consisting of patient representatives and medical specialists published a framework for such a definition, without reaching a final recommendation.BACKGROUNDRemission is the stated goal for both patient and caregiver, but consensus on a definition of remission has been lacking. Previously, an international task force consisting of patient representatives and medical specialists published a framework for such a definition, without reaching a final recommendation.Several systematic literature reviews were performed and specific research questions examined in suitably chosen data sets. The findings were discussed, reformulated as recommendations and voted on.METHODSSeveral systematic literature reviews were performed and specific research questions examined in suitably chosen data sets. The findings were discussed, reformulated as recommendations and voted on.Based on data from the literature and several SLE-specific data sets, a set of recommendations was endorsed. Ultimately, the DORIS Task Force recommended a single definition of remission in SLE, based on clinical systemic lupus erythematosus disease activitiy index (SLEDAI)=0, Evaluator's Global Assessment <0.5 (0-3), prednisolone 5 mg/day or less, and stable antimalarials, immunosuppressives, and biologics.RESULTSBased on data from the literature and several SLE-specific data sets, a set of recommendations was endorsed. Ultimately, the DORIS Task Force recommended a single definition of remission in SLE, based on clinical systemic lupus erythematosus disease activitiy index (SLEDAI)=0, Evaluator's Global Assessment <0.5 (0-3), prednisolone 5 mg/day or less, and stable antimalarials, immunosuppressives, and biologics.The 2021 DORIS definition of remission in SLE is recommended for use in clinical care, education, and research including clinical trials and observational studies.CONCLUSIONThe 2021 DORIS definition of remission in SLE is recommended for use in clinical care, education, and research including clinical trials and observational studies. Objective To achieve consensus on a definition of remission in SLE (DORIS).Background Remission is the stated goal for both patient and caregiver, but consensus on a definition of remission has been lacking. Previously, an international task force consisting of patient representatives and medical specialists published a framework for such a definition, without reaching a final recommendation.Methods Several systematic literature reviews were performed and specific research questions examined in suitably chosen data sets. The findings were discussed, reformulated as recommendations and voted on.Results Based on data from the literature and several SLE-specific data sets, a set of recommendations was endorsed. Ultimately, the DORIS Task Force recommended a single definition of remission in SLE, based on clinical systemic lupus erythematosus disease activitiy index (SLEDAI)=0, Evaluator’s Global Assessment <0.5 (0–3), prednisolone 5 mg/day or less, and stable antimalarials, immunosuppressives, and biologics.Conclusion The 2021 DORIS definition of remission in SLE is recommended for use in clinical care, education, and research including clinical trials and observational studies. |
| Author | Werth, Victoria P Bertsias, George Jacobsen, Søren Pons-Estel, Guillermo Zakharhova, Elena Inanc, Murat Jayne, David Bruce, Ian N Boumpas, Dimitrios T Olesinska, Marzena Helena Voss, Anne Brunner, Hermine Aringer, Martin Bootsma, Hendrika Faria, Raquel Bonfá, Eloisa Morand, Eric Bae, Sang-Cheol Ward, Michael M Fischer, Rebecca Teng, Y K Onno Kuhn, Annegret Schneider, Matthias Doria, Andrea Costedoat-Chalumeau, Nathalie Tsang-A-Sjoe, Michel Petri, Michelle A Isenberg, David Mosca, Marta Askanase, Anca D Coney, Cindy Pons-Estel, Bernardo A Houssiau, Frédéric A Schoenfeld, Yehuda Tincani, Angela Nikpour, Mandana Cervera, Ricard Ugarte-Gil, Manuel Francisco Limper, Maarten Navarra, Sandra Fritsch-Stork, Ruth Rahman, Anisur Rubio, Blanca Dörner, Thomas Czirják, László Mariette, Xavier Vasconcelos, Carlos Aranow, Cynthia Voskuyl, Alexandre Alarcon, Graciela Smolen, Josef Clarke, Ann Elaine van Vollenhoven, Ronald F Arnaud, Laurent van Leeuw, Bernadette Romero-Diaz, Juanita Gordon, Caroline |
| AuthorAffiliation | 55 Unit for Multidisciplinary Research in Biomedicine , Porto , Portugal 6 Division of Rheumatology , Johns Hopkins University School of Medicine , Baltimore , Maryland , USA 13 Strasbourg Federation of Translational Medicine (FMTS) , University of Strasbourg , Strasbourg , France 46 Institute of Rheumatology , Warsaw , Poland 28 Medicine , National and Kapodestrian University of Athens , Athens , Greece 10 Rheumatology Department , Hospital Guillermo Almenara Irigoyen , EsSalud , Lima , Peru 43 Public Assistance , Paris Hospitals, Paris Saclay University , Le Kremlin-Bicetre , France 48 Immunology and Rheumatology , National Institute of Medical Sciences and Nutrition Salvador Zubirán , Mexico City , Mexico 34 Clinical Immunology Unit , Porto Hospital and University Center , Porto , Portugal 44 Rheumatology , University of Santo Tomas Hospital , Manila , Philippines 37 Internal Medicine Rheumatology , University of Istanbul , Istanbul , Turkey 25 Columbia University Medical Center , New York , N |
| AuthorAffiliation_xml | – name: 2 Rheumatology, Clinical Immunology and Allergy , University Hospital of Heraklion , Heraklion , Greece – name: 14 The University of Manchester , Manchester , UK – name: 52 Nephrology , Leiden University Medical Centre , Leiden , The Netherlands – name: 8 Medicine (Rheumatology) , University College London , London , UK – name: 43 Public Assistance , Paris Hospitals, Paris Saclay University , Le Kremlin-Bicetre , France – name: 18 Pole of Rheumatic Pathologies , Catholic University of Louvain, Institute for Experimental and Clinical Research , Brussels , Belgium – name: 19 Rheumatology Department , Saint-Luc University Clinics , Brussels , Belgium – name: 30 University of Calgary , Calgary , Alberta , Canada – name: 11 VU University Medical Center , Amsterdam , The Netherlands – name: 60 Autoimmune and Musculoskeletal Disease , The Feinstein Institute for Medical Research , Manhasset , New York , USA – name: 37 Internal Medicine Rheumatology , University of Istanbul , Istanbul , Turkey – name: 46 Institute of Rheumatology , Warsaw , Poland – name: 31 Lupus Foundation of America , Washington , District of Columbia , USA – name: 40 University of Meunster , Meunster , Germany – name: 50 Rheumatology , University of Sao Paulo Faculty of Medicine , Sao Paulo , Brazil – name: 39 Medicine , University of Cambridge School of Clinical Medicine , Cambridge , UK – name: 9 School of Medicine , Universidad Cientifica del Sur , Lima , Peru – name: 34 Clinical Immunology Unit , Porto Hospital and University Center , Porto , Portugal – name: 51 Medical University of Vienna , Wien , Austria – name: 53 Rheumatology , University of Brescia , Brescia , Italy – name: 41 Lupus Europe , Brussels , Belgium – name: 58 Dermatology , University of Pennsylvania , Philadelphia , Pennsylvania , USA – name: 26 Rheumatology , Hanyang University Seoul Hospital , Seoul , Korea (the Republic of) – name: 17 Rheumatology Research Group , University of Birmingham , Birmingham , UK – name: 12 Department of Rheumatology , Strasbourg University Hospitals , Strasbourg , France – name: 32 Department of Rheumatology and Immunology , University of Pecs , Pecs , Hungary – name: 59 Rheumatology , A I Yevdokimov Moscow State University of Medicine and Dentistry of the Ministry of Healthcare of the Russian Federation Faculty of Dentistry , Moskva , Russian Federation – name: 25 Columbia University Medical Center , New York , New York , USA – name: 49 Zabludowicz Center for Autoimmune Diseases , Sheba Medical Center , Tel Hashomer , Tel Aviv , Israel – name: 36 First Medical Department , Hanusch Hospital , Wien , Austria – name: 44 Rheumatology , University of Santo Tomas Hospital , Manila , Philippines – name: 3 Division of Rheumatology , University of Padova , Padova , Italy – name: 13 Strasbourg Federation of Translational Medicine (FMTS) , University of Strasbourg , Strasbourg , France – name: 42 Rheumatology & Clinical Immunology , UMC Utrecht , Utrecht , The Netherlands – name: 5 Monash Medical Centre , Melbourne , Victoria , Australia – name: 10 Rheumatology Department , Hospital Guillermo Almenara Irigoyen , EsSalud , Lima , Peru – name: 35 Rheumatology , Heinrich-Heine-University , Duesseldorf , Germany – name: 21 Policlinic for Rheumatology & Hiller Research Centre for Rheumatology , Heinrich-Heine-University , Düsseldorf , Germany – name: 55 Unit for Multidisciplinary Research in Biomedicine , Porto , Portugal – name: 1 Department of Rheumatology , Amsterdam Rheumatology and Immunology Center , Amsterdam , The Netherlands – name: 29 Cincinnati Children's Hospital Medical Center , Cincinnati , Ohio , USA – name: 47 Regional Center for Autoimmune and Rheumatic Diseases (GO-CREAR) , Rosario , Argentina – name: 6 Division of Rheumatology , Johns Hopkins University School of Medicine , Baltimore , Maryland , USA – name: 45 Medicine and Rheumatology , University of Melbourne , Fitzroy , Victoria , Australia – name: 15 Hospital Clinic of Barcelona , Barcelona , Spain – name: 22 NIH , Bethesda , Maryland , USA – name: 48 Immunology and Rheumatology , National Institute of Medical Sciences and Nutrition Salvador Zubirán , Mexico City , Mexico – name: 27 UMC Groningen , Groningen , The Netherlands – name: 38 Rheumatology , Rigshospitalet, Copenhagen University Hospital , Copenhagen , Denmark – name: 57 Department of Clinical Research , University of Southern Denmark Faculty of Health Sciences , Odense , Denmark – name: 4 Centre for Rheumatology , University College London , London , UK – name: 54 Rheumatology , VU University Medical Centre Amsterdam , Amsterdam , The Netherlands – name: 33 Charite University Hospitals Berlin , Berlin , Germany – name: 24 Dresden University Hospital , Dresden , Germany – name: 56 Department of Rheumatology , Odense University Hospital , Odense , Denmark – name: 20 University of Pisa , Pisa , Italy – name: 28 Medicine , National and Kapodestrian University of Athens , Athens , Greece – name: 16 Cochin Hospital , Paris , France – name: 7 Rheumatology , Provincial Hospital of Rosario , Rosario , Santa Fe , Argentina – name: 23 University of Alabama , Birmingham , Alabama , USA |
| Author_xml | – sequence: 1 givenname: Ronald F orcidid: 0000-0001-6438-8663 surname: van Vollenhoven fullname: van Vollenhoven, Ronald F email: r.vanvollenhoven@amsterdamumc.nl organization: Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, Amsterdam, The Netherlands – sequence: 2 givenname: George surname: Bertsias fullname: Bertsias, George organization: Rheumatology, Clinical Immunology and Allergy, University Hospital of Heraklion, Heraklion, Greece – sequence: 3 givenname: Andrea orcidid: 0000-0003-0548-4983 surname: Doria fullname: Doria, Andrea organization: Division of Rheumatology, University of Padova, Padova, Italy – sequence: 4 givenname: David surname: Isenberg fullname: Isenberg, David organization: Centre for Rheumatology, University College London, London, UK – sequence: 5 givenname: Eric orcidid: 0000-0002-9507-3338 surname: Morand fullname: Morand, Eric organization: Monash Medical Centre, Melbourne, Victoria, Australia – sequence: 6 givenname: Michelle A orcidid: 0000-0003-1441-5373 surname: Petri fullname: Petri, Michelle A organization: Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA – sequence: 7 givenname: Bernardo A orcidid: 0000-0003-2518-0266 surname: Pons-Estel fullname: Pons-Estel, Bernardo A organization: Rheumatology, Provincial Hospital of Rosario, Rosario, Santa Fe, Argentina – sequence: 8 givenname: Anisur surname: Rahman fullname: Rahman, Anisur organization: Medicine (Rheumatology), University College London, London, UK – sequence: 9 givenname: Manuel Francisco orcidid: 0000-0003-1728-1999 surname: Ugarte-Gil fullname: Ugarte-Gil, Manuel Francisco organization: Rheumatology Department, Hospital Guillermo Almenara Irigoyen, EsSalud, Lima, Peru – sequence: 10 givenname: Alexandre surname: Voskuyl fullname: Voskuyl, Alexandre organization: VU University Medical Center, Amsterdam, The Netherlands – sequence: 11 givenname: Laurent orcidid: 0000-0002-8077-8394 surname: Arnaud fullname: Arnaud, Laurent organization: Strasbourg Federation of Translational Medicine (FMTS), University of Strasbourg, Strasbourg, France – sequence: 12 givenname: Ian N orcidid: 0000-0003-3047-500X surname: Bruce fullname: Bruce, Ian N organization: The University of Manchester, Manchester, UK – sequence: 13 givenname: Ricard surname: Cervera fullname: Cervera, Ricard organization: Hospital Clinic of Barcelona, Barcelona, Spain – sequence: 14 givenname: Nathalie surname: Costedoat-Chalumeau fullname: Costedoat-Chalumeau, Nathalie organization: Cochin Hospital, Paris, France – sequence: 15 givenname: Caroline surname: Gordon fullname: Gordon, Caroline organization: Rheumatology Research Group, University of Birmingham, Birmingham, UK – sequence: 16 givenname: Frédéric A orcidid: 0000-0003-1451-083X surname: Houssiau fullname: Houssiau, Frédéric A organization: Rheumatology Department, Saint-Luc University Clinics, Brussels, Belgium – sequence: 17 givenname: Marta surname: Mosca fullname: Mosca, Marta organization: University of Pisa, Pisa, Italy – sequence: 18 givenname: Matthias surname: Schneider fullname: Schneider, Matthias organization: Policlinic for Rheumatology & Hiller Research Centre for Rheumatology, Heinrich-Heine-University, Düsseldorf, Germany – sequence: 19 givenname: Michael M surname: Ward fullname: Ward, Michael M organization: NIH, Bethesda, Maryland, USA – sequence: 20 givenname: Graciela surname: Alarcon fullname: Alarcon, Graciela organization: University of Alabama, Birmingham, Alabama, USA – sequence: 21 givenname: Martin orcidid: 0000-0003-4471-8375 surname: Aringer fullname: Aringer, Martin organization: Dresden University Hospital, Dresden, Germany – sequence: 22 givenname: Anca D surname: Askanase fullname: Askanase, Anca D organization: Columbia University Medical Center, New York, New York, USA – sequence: 23 givenname: Sang-Cheol orcidid: 0000-0003-4658-1093 surname: Bae fullname: Bae, Sang-Cheol organization: Rheumatology, Hanyang University Seoul Hospital, Seoul, Korea (the Republic of) – sequence: 24 givenname: Hendrika surname: Bootsma fullname: Bootsma, Hendrika organization: UMC Groningen, Groningen, The Netherlands – sequence: 25 givenname: Dimitrios T orcidid: 0000-0002-9812-4671 surname: Boumpas fullname: Boumpas, Dimitrios T organization: Medicine, National and Kapodestrian University of Athens, Athens, Greece – sequence: 26 givenname: Hermine orcidid: 0000-0001-9478-2987 surname: Brunner fullname: Brunner, Hermine organization: Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA – sequence: 27 givenname: Ann Elaine surname: Clarke fullname: Clarke, Ann Elaine organization: University of Calgary, Calgary, Alberta, Canada – sequence: 28 givenname: Cindy surname: Coney fullname: Coney, Cindy organization: Lupus Foundation of America, Washington, District of Columbia, USA – sequence: 29 givenname: László surname: Czirják fullname: Czirják, László organization: Department of Rheumatology and Immunology, University of Pecs, Pecs, Hungary – sequence: 30 givenname: Thomas orcidid: 0000-0002-6478-7725 surname: Dörner fullname: Dörner, Thomas organization: Charite University Hospitals Berlin, Berlin, Germany – sequence: 31 givenname: Raquel surname: Faria fullname: Faria, Raquel organization: Clinical Immunology Unit, Porto Hospital and University Center, Porto, Portugal – sequence: 32 givenname: Rebecca surname: Fischer fullname: Fischer, Rebecca organization: Rheumatology, Heinrich-Heine-University, Duesseldorf, Germany – sequence: 33 givenname: Ruth surname: Fritsch-Stork fullname: Fritsch-Stork, Ruth organization: First Medical Department, Hanusch Hospital, Wien, Austria – sequence: 34 givenname: Murat surname: Inanc fullname: Inanc, Murat organization: Internal Medicine Rheumatology, University of Istanbul, Istanbul, Turkey – sequence: 35 givenname: Søren orcidid: 0000-0002-5654-4993 surname: Jacobsen fullname: Jacobsen, Søren organization: Rheumatology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark – sequence: 36 givenname: David surname: Jayne fullname: Jayne, David organization: Medicine, University of Cambridge School of Clinical Medicine, Cambridge, UK – sequence: 37 givenname: Annegret surname: Kuhn fullname: Kuhn, Annegret organization: University of Meunster, Meunster, Germany – sequence: 38 givenname: Bernadette surname: van Leeuw fullname: van Leeuw, Bernadette organization: Lupus Europe, Brussels, Belgium – sequence: 39 givenname: Maarten surname: Limper fullname: Limper, Maarten organization: Rheumatology & Clinical Immunology, UMC Utrecht, Utrecht, The Netherlands – sequence: 40 givenname: Xavier surname: Mariette fullname: Mariette, Xavier organization: Public Assistance, Paris Hospitals, Paris Saclay University, Le Kremlin-Bicetre, France – sequence: 41 givenname: Sandra surname: Navarra fullname: Navarra, Sandra organization: Rheumatology, University of Santo Tomas Hospital, Manila, Philippines – sequence: 42 givenname: Mandana surname: Nikpour fullname: Nikpour, Mandana organization: Medicine and Rheumatology, University of Melbourne, Fitzroy, Victoria, Australia – sequence: 43 givenname: Marzena Helena surname: Olesinska fullname: Olesinska, Marzena Helena organization: Institute of Rheumatology, Warsaw, Poland – sequence: 44 givenname: Guillermo surname: Pons-Estel fullname: Pons-Estel, Guillermo organization: Regional Center for Autoimmune and Rheumatic Diseases (GO-CREAR), Rosario, Argentina – sequence: 45 givenname: Juanita surname: Romero-Diaz fullname: Romero-Diaz, Juanita organization: Immunology and Rheumatology, National Institute of Medical Sciences and Nutrition Salvador Zubirán, Mexico City, Mexico – sequence: 46 givenname: Blanca surname: Rubio fullname: Rubio, Blanca organization: Lupus Europe, Brussels, Belgium – sequence: 47 givenname: Yehuda surname: Schoenfeld fullname: Schoenfeld, Yehuda organization: Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel Hashomer, Tel Aviv, Israel – sequence: 48 givenname: Eloisa surname: Bonfá fullname: Bonfá, Eloisa organization: Rheumatology, University of Sao Paulo Faculty of Medicine, Sao Paulo, Brazil – sequence: 49 givenname: Josef surname: Smolen fullname: Smolen, Josef organization: Medical University of Vienna, Wien, Austria – sequence: 50 givenname: Y K Onno orcidid: 0000-0001-9920-2195 surname: Teng fullname: Teng, Y K Onno organization: Nephrology, Leiden University Medical Centre, Leiden, The Netherlands – sequence: 51 givenname: Angela surname: Tincani fullname: Tincani, Angela organization: Rheumatology, University of Brescia, Brescia, Italy – sequence: 52 givenname: Michel orcidid: 0000-0002-4982-3505 surname: Tsang-A-Sjoe fullname: Tsang-A-Sjoe, Michel organization: Rheumatology, VU University Medical Centre Amsterdam, Amsterdam, The Netherlands – sequence: 53 givenname: Carlos surname: Vasconcelos fullname: Vasconcelos, Carlos organization: Unit for Multidisciplinary Research in Biomedicine, Porto, Portugal – sequence: 54 givenname: Anne surname: Voss fullname: Voss, Anne organization: Department of Clinical Research, University of Southern Denmark Faculty of Health Sciences, Odense, Denmark – sequence: 55 givenname: Victoria P orcidid: 0000-0003-3030-5369 surname: Werth fullname: Werth, Victoria P organization: Dermatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA – sequence: 56 givenname: Elena surname: Zakharhova fullname: Zakharhova, Elena organization: Rheumatology, A I Yevdokimov Moscow State University of Medicine and Dentistry of the Ministry of Healthcare of the Russian Federation Faculty of Dentistry, Moskva, Russian Federation – sequence: 57 givenname: Cynthia orcidid: 0000-0001-9299-0053 surname: Aranow fullname: Aranow, Cynthia organization: Autoimmune and Musculoskeletal Disease, The Feinstein Institute for Medical Research, Manhasset, New York, USA |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34819388$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kl1r1jAUgINM3If7Ad5IwRtvqvlqmnohjDn1hRcGTq9DkiYzr2nymrSC_35pu-k2UCikOXnOw-GccwwOQgwGgBcIvkGIsLd-2k-5xhCjGkLYEP4EHOFy1rzt4MG9_0NwmvOuMAgj0nL4DBwSylFHOD8CchZUHy6_bK6q3lgX3OhiqKKtkhlczvPFhepqe_GuKq_Sl7iOw2BCL2cyVzbFoZIzNZoUlmChRpl_VDYmbZ6Dp1b6bE5vzxPw7ePF1_PP9fby0-b8bFurpmvH2lBLVQ87SJHSlktOGs1aKxGRjdYESta2GGHVq4401iIrYWM7xbm1jYKkIydgs3r7KHdin9wg028RpRNLIKZrIdPotDdC09nUEciQpYwTZXCLTGkOM0hCRYvr_eraT2owvTZhTNI_kD58Ce67uI6_BGeIluEUwetbQYo_J5NHUZqpjfcymDhlgRnEjDSUNQV99Qjdxak00i8U4uVbqJf3K_pTyt0kC9CugE4x52Ss0G5cplEKdF4gKOa1EcvaiHnqYl2bkokeZd7J_5dTrzlq2P2t99_8DbeF05I |
| CitedBy_id | crossref_primary_10_1177_20406223231160688 crossref_primary_10_1016_j_intimp_2023_111156 crossref_primary_10_1007_s10067_024_07101_4 crossref_primary_10_1016_j_clicom_2023_10_002 crossref_primary_10_1093_rheumatology_keac316 crossref_primary_10_1136_ard_2024_225686 crossref_primary_10_1016_S2665_9913_22_00304_6 crossref_primary_10_1093_rheumatology_kead407 crossref_primary_10_1136_lupus_2024_001207 crossref_primary_10_1080_13543784_2023_2264172 crossref_primary_10_1016_j_ejim_2022_03_016 crossref_primary_10_1055_a_2308_5009 crossref_primary_10_1136_ard_2023_224919 crossref_primary_10_1093_mr_roac100 crossref_primary_10_1186_s41927_022_00300_z crossref_primary_10_3389_fmed_2023_1159794 crossref_primary_10_1016_S2665_9913_24_00121_8 crossref_primary_10_1136_rmdopen_2023_003270 crossref_primary_10_1186_s12916_024_03729_w crossref_primary_10_2147_JIR_S504995 crossref_primary_10_5114_reum_170845 crossref_primary_10_1136_lupus_2024_001206 crossref_primary_10_1136_ard_2022_223429 crossref_primary_10_3390_pathogens13110934 crossref_primary_10_1016_j_imlet_2024_106962 crossref_primary_10_1136_rmdopen_2024_005072 crossref_primary_10_1002_acr_25334 crossref_primary_10_1016_S2665_9913_23_00209_6 crossref_primary_10_1111_joim_13752 crossref_primary_10_1016_j_reuma_2024_07_004 crossref_primary_10_1177_09612033231171343 crossref_primary_10_1016_j_jtauto_2025_100274 crossref_primary_10_1111_trf_17475 crossref_primary_10_1016_j_reumae_2024_10_003 crossref_primary_10_1002_art_43097 crossref_primary_10_1136_ard_2024_225613 crossref_primary_10_1136_ard_2023_225319 crossref_primary_10_1136_lupus_2024_001434 crossref_primary_10_1136_ard_2022_222748 crossref_primary_10_1136_lupus_2024_001196 crossref_primary_10_1177_1759720X221096367 crossref_primary_10_1016_j_clim_2023_109296 crossref_primary_10_1002_acr2_11733 crossref_primary_10_3390_biom13020367 crossref_primary_10_1093_rheumatology_keae270 crossref_primary_10_1177_1357633X231181714 crossref_primary_10_1007_s00393_024_01534_7 crossref_primary_10_3390_jcm11133587 crossref_primary_10_5114_reum_2022_115667 crossref_primary_10_1093_rheumatology_kead460 crossref_primary_10_1136_lupus_2023_001024 crossref_primary_10_1093_rheumatology_keae278 crossref_primary_10_1093_rheumatology_kead696 crossref_primary_10_1016_j_autrev_2024_103687 crossref_primary_10_1016_S0140_6736_23_01126_1 crossref_primary_10_1093_rheumatology_keae547 crossref_primary_10_1136_ard_2023_224762 crossref_primary_10_1016_S2665_9913_22_00358_7 crossref_primary_10_1016_j_clim_2024_110214 crossref_primary_10_1016_j_ekir_2023_05_012 crossref_primary_10_1016_j_rceng_2023_11_001 crossref_primary_10_1136_lupus_2022_000841 crossref_primary_10_1177_09612033241273023 crossref_primary_10_1007_s00384_021_04091_6 crossref_primary_10_1136_lupus_2023_000901 crossref_primary_10_1002_iid3_1362 crossref_primary_10_1136_lupus_2022_000681 crossref_primary_10_1093_rheumatology_keae381 crossref_primary_10_1177_09612033241238055 crossref_primary_10_1007_s00296_024_05589_2 crossref_primary_10_1136_lupus_2024_001217 crossref_primary_10_1016_S2665_9913_24_00152_8 crossref_primary_10_1136_lupus_2024_001336 crossref_primary_10_1093_rheumatology_keaf107 crossref_primary_10_1136_ard_2023_224152 crossref_primary_10_1136_bmjopen_2024_086055 crossref_primary_10_1002_acr_25305 crossref_primary_10_3389_fimmu_2023_1277267 crossref_primary_10_1093_rheumatology_kead568 crossref_primary_10_1186_s13075_024_03389_4 crossref_primary_10_1038_s41584_021_00739_3 crossref_primary_10_1136_ard_2023_224795 crossref_primary_10_1177_09612033241266987 crossref_primary_10_1016_j_autrev_2023_103374 crossref_primary_10_1016_j_jaip_2024_08_033 crossref_primary_10_1038_s41584_023_00925_5 crossref_primary_10_1186_s43162_024_00389_3 crossref_primary_10_7717_peerj_18028 crossref_primary_10_1016_j_jbspin_2024_105756 crossref_primary_10_1093_labmed_lmae035 crossref_primary_10_1056_NEJMoa2308917 crossref_primary_10_1093_mr_road078 crossref_primary_10_1016_S2352_4642_22_00224_3 crossref_primary_10_1136_ard_2023_225369 crossref_primary_10_1177_20406223241289074 crossref_primary_10_3389_fped_2023_1272065 crossref_primary_10_1007_s00296_024_05593_6 crossref_primary_10_1177_09612033231202878 crossref_primary_10_1093_rheumatology_kead166 crossref_primary_10_1007_s00296_023_05497_x crossref_primary_10_1016_j_berh_2022_101814 crossref_primary_10_1016_j_berh_2024_101939 crossref_primary_10_1093_rheumatology_kead159 crossref_primary_10_1186_s13075_024_03397_4 crossref_primary_10_1016_j_rce_2023_11_001 crossref_primary_10_1177_09612033231215386 crossref_primary_10_1016_S2665_9913_22_00107_2 crossref_primary_10_3389_flupu_2024_1442013 crossref_primary_10_1016_j_clim_2022_109186 crossref_primary_10_1007_s40620_024_02085_5 crossref_primary_10_5114_reum_190257 crossref_primary_10_1080_1744666X_2023_2156339 crossref_primary_10_1186_s43166_023_00187_9 crossref_primary_10_1016_j_revmed_2023_04_320 crossref_primary_10_1002_acr2_11550 crossref_primary_10_1016_S1286_935X_24_49136_3 crossref_primary_10_1093_mr_roae058 crossref_primary_10_1055_s_0043_1771049 crossref_primary_10_1016_j_jacig_2024_100365 crossref_primary_10_1093_rheumatology_keae120 crossref_primary_10_1177_09612033241261746 crossref_primary_10_1093_rheumatology_keac185 crossref_primary_10_1038_s41591_022_02017_5 crossref_primary_10_1093_rheumatology_keaf057 crossref_primary_10_1097_BOR_0000000000001062 crossref_primary_10_1093_rheumatology_keae631 crossref_primary_10_1093_rheumatology_keac334 crossref_primary_10_1097_RHU_0000000000002102 crossref_primary_10_1038_s41584_023_00948_y crossref_primary_10_7759_cureus_73099 crossref_primary_10_1136_ard_2022_222991 crossref_primary_10_3390_medicina59122097 crossref_primary_10_1007_s00467_024_06405_6 crossref_primary_10_1007_s40744_023_00601_w crossref_primary_10_1177_09612033241249785 crossref_primary_10_1007_s00393_024_01551_6 crossref_primary_10_1136_ard_2022_223328 crossref_primary_10_1016_S2665_9913_24_00162_0 crossref_primary_10_3390_jcm12093348 crossref_primary_10_1007_s00393_022_01250_0 crossref_primary_10_1136_lupus_2021_000616 crossref_primary_10_1136_lupus_2024_001144 crossref_primary_10_1136_lupus_2022_000657 crossref_primary_10_1007_s00296_023_05306_5 crossref_primary_10_1016_S2665_9913_22_00310_1 crossref_primary_10_1007_s12325_022_02098_1 crossref_primary_10_1142_S2661341723300057 crossref_primary_10_1038_s41584_023_00993_7 crossref_primary_10_1016_j_berh_2023_101896 crossref_primary_10_1016_j_anai_2023_08_609 crossref_primary_10_1016_j_eclinm_2024_102476 crossref_primary_10_1097_BOR_0000000000000913 crossref_primary_10_1007_s10067_023_06523_w crossref_primary_10_1007_s00296_024_05772_5 crossref_primary_10_1016_j_ard_2025_01_016 crossref_primary_10_1007_s00108_023_01624_9 crossref_primary_10_1136_ard_2022_222487 crossref_primary_10_3389_fimmu_2025_1546306 crossref_primary_10_1007_s00393_023_01359_w crossref_primary_10_1136_lupus_2023_001111 crossref_primary_10_1136_lupus_2024_001254 crossref_primary_10_3389_flupu_2024_1459949 crossref_primary_10_1016_j_autrev_2025_103773 crossref_primary_10_1093_rheumatology_kead097 crossref_primary_10_1136_lupus_2024_001375 crossref_primary_10_1159_000529675 crossref_primary_10_3389_fmed_2022_1092325 crossref_primary_10_1093_rheumatology_keae341 crossref_primary_10_1136_bmj_2022_073980 crossref_primary_10_3899_jrheum_2024_0053 |
| Cites_doi | 10.1136/annrheumdis-2013-205139 10.1093/rheumatology/kew377 10.1093/rheumatology/key349 10.1136/annrheumdis-2017-211814 10.1136/rmdopen-2019-000955 10.1111/1756-185X.13431 10.1177/0961203319876998 10.1136/annrheumdis-2020-217070 10.1136/annrheumdis-2016-209519 10.1038/s41584-019-0170-5 10.1177/0961203319826693 10.1136/annrheumdis-2015-207347 10.1016/j.rdc.2019.07.002 10.1136/annrheumdis-2016-209489 10.1136/annrheumdis-2016-210154 10.1136/annrheumdis-2020-eular.2037 10.1002/art.40571 10.1002/acr.24009 10.1136/annrheumdis-2020-eular.2507 |
| ContentType | Journal Article |
| Copyright | Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2022 Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2022 |
| Copyright_xml | – notice: Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. – notice: Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. – notice: 2022 Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2022 |
| DBID | 9YT ACMMV AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR BTHHO CCPQU DWQXO FYUFA GHDGH K9. PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
| DOI | 10.1136/lupus-2021-000538 |
| DatabaseName | BMJ Open Access Journals BMJ Journals:Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials - QC ProQuest Central BMJ Journals ProQuest One ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete ProQuest Health & Medical Research Collection Health Research Premium Collection ProQuest One Academic UKI Edition BMJ Journals ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | Publicly Available Content Database MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: ACMMV name: BMJ Journals:Open Access url: https://journals.bmj.com/ sourceTypes: Publisher – sequence: 5 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 2053-8790 |
| ExternalDocumentID | oai_doaj_org_article_c4212b93061f4683be271e1376e1a0b4 PMC8614136 34819388 10_1136_lupus_2021_000538 lupusscimed |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GrantInformation_xml | – fundername: UCB Pharma grantid: n/a – fundername: GlaxoSmithKline grantid: n/a funderid: http://dx.doi.org/10.13039/100004330 – fundername: ; grantid: n/a |
| GroupedDBID | 53G 5VS 7X7 8FI 8FJ 9YT ABUWG ACGFS ACMMV ADBBV AFKRA ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV BENPR BPHCQ BTFSW BTHHO CCPQU DIK FRJ FYUFA GROUPED_DOAJ H13 HMCUK HYE KQ8 M48 M~E OK1 PGMZT PHGZT PIMPY PQQKQ PROAC RHI RMJ RPM UKHRP AAYXX ADRAZ CITATION PHGZM CGR CUY CVF ECM EIF NPM 3V. 7XB 8FK AZQEC DWQXO K9. PJZUB PKEHL PPXIY PQEST PQUKI PRINS 7X8 5PM PUEGO |
| ID | FETCH-LOGICAL-b597t-e4f4bd09041bcf8a835c67fa13a5cc30a677212bdb935ff1fa05f9b88ff5b0393 |
| IEDL.DBID | 9YT |
| ISSN | 2053-8790 |
| IngestDate | Wed Aug 27 01:22:41 EDT 2025 Thu Aug 21 14:06:47 EDT 2025 Fri Jul 11 11:29:29 EDT 2025 Fri Jul 25 22:54:31 EDT 2025 Thu Apr 24 04:15:03 EDT 2025 Tue Jul 01 03:07:56 EDT 2025 Thu Apr 24 23:06:09 EDT 2025 Thu Apr 24 22:50:12 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | systemic therapeutics outcome assessment lupus erythematosus healthcare |
| Language | English |
| License | This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-b597t-e4f4bd09041bcf8a835c67fa13a5cc30a677212bdb935ff1fa05f9b88ff5b0393 |
| Notes | Original research ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| ORCID | 0000-0002-6478-7725 0000-0001-9478-2987 0000-0003-1451-083X 0000-0002-9507-3338 0000-0003-1728-1999 0000-0003-4658-1093 0000-0002-4982-3505 0000-0003-2518-0266 0000-0001-9920-2195 0000-0003-3047-500X 0000-0003-4471-8375 0000-0001-9299-0053 0000-0001-6438-8663 0000-0002-8077-8394 0000-0002-5654-4993 0000-0003-1441-5373 0000-0003-0548-4983 0000-0002-9812-4671 0000-0003-3030-5369 |
| OpenAccessLink | https://lupus.bmj.com/content/8/1/e000538.full |
| PMID | 34819388 |
| PQID | 2601801865 |
| PQPubID | 2041883 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_c4212b93061f4683be271e1376e1a0b4 pubmedcentral_primary_oai_pubmedcentral_nih_gov_8614136 proquest_miscellaneous_2602635465 proquest_journals_2601801865 pubmed_primary_34819388 crossref_citationtrail_10_1136_lupus_2021_000538 crossref_primary_10_1136_lupus_2021_000538 bmj_journals_10_1136_lupus_2021_000538 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2021-11-01 |
| PublicationDateYYYYMMDD | 2021-11-01 |
| PublicationDate_xml | – month: 11 year: 2021 text: 2021-11-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England – name: London – name: BMA House, Tavistock Square, London, WC1H 9JR |
| PublicationSeriesTitle | Original research |
| PublicationTitle | Lupus science & medicine |
| PublicationTitleAbbrev | Lupus Sci Med |
| PublicationTitleAlternate | Lupus Sci Med |
| PublicationYear | 2021 |
| Publisher | Lupus Foundation of America BMJ Publishing Group LTD BMJ Publishing Group |
| Publisher_xml | – name: Lupus Foundation of America – name: BMJ Publishing Group LTD – name: BMJ Publishing Group |
| References | Alarcón, Ugarte-Gil, Pons-Estel (R14) 2019; 28 Zen, Iaccarino, Gatto (R18) 2015; 74 Kandane-Rathnayake, Golder, Louthrenoo (R21) 2019; 22 Ugarte-Gil, Mendoza Pinto, Pons-Estel (R5) 2020; 79 Saccon, Zen, Gatto (R20) 2020; 79 Zen, Iaccarino, Gatto (R19) 2017; 76 Pons-Estel, Ugarte-Gil, Harvey (R9) 2020; 72 Tsang-A-Sjoe, Bultink, Heslinga (R7) 2019; 58 Tsang-A-Sjoe, Bultink, Heslinga (R6) 2017; 56 Ugarte-Gil, Pons-Estel, Vila (R13) 2020; 26 Ugarte-Gil, Gamboa-Cardenas, Reategui-Sokolova (R12) 2020; 72 van Vollenhoven, Mosca, Bertsias (R3) 2014; 73 van Vollenhoven, Voskuyl, Bertsias (R4) 2017; 76 Ugarte-Gil, Wojdyla, Pons-Estel (R8) 2017; 76 Ugarte-Gil, Pons-Estel, Vila (R15) 2019; 5 Ugarte-Gil, Gamboa-Cárdenas, Reátegui-Sokolova (R10) 2020; 72 Petri, Magder (R17) 2018; 70 van Vollenhoven (R1) 2019; 15 Wilhelm, Magder, Petri (R16) 2017; 76 Reátegui-Sokolova, Rodríguez-Bellido, Gamboa-Cárdenas (R11) 2019; 28 Zhang, Kavanaugh (R2) 2019; 45 Zhang (2024052109573893000_8.1.e000538.2) 2019; 45 Tsang-A-Sjoe (2024052109573893000_8.1.e000538.7) 2019; 58 Petri (2024052109573893000_8.1.e000538.17) 2018; 70 Kandane-Rathnayake (2024052109573893000_8.1.e000538.21) 2019; 22 Alarcón (2024052109573893000_8.1.e000538.14) 2019; 28 2024052109573893000_8.1.e000538.15 2024052109573893000_8.1.e000538.12 2024052109573893000_8.1.e000538.19 2024052109573893000_8.1.e000538.18 2024052109573893000_8.1.e000538.16 Ugarte-Gil (2024052109573893000_8.1.e000538.13) 2020; 26 2024052109573893000_8.1.e000538.1 Ugarte-Gil (2024052109573893000_8.1.e000538.10) 2020; 72 2024052109573893000_8.1.e000538.3 2024052109573893000_8.1.e000538.4 2024052109573893000_8.1.e000538.5 2024052109573893000_8.1.e000538.20 2024052109573893000_8.1.e000538.6 2024052109573893000_8.1.e000538.8 2024052109573893000_8.1.e000538.9 Reátegui-Sokolova (2024052109573893000_8.1.e000538.11) 2019; 28 35135871 - Lupus Sci Med. 2022 Feb;9(1) |
| References_xml | – volume: 73 start-page: 958 year: 2014 ident: R3 article-title: Treat-to-target in systemic lupus erythematosus: recommendations from an international Task force publication-title: Ann Rheum Dis doi: 10.1136/annrheumdis-2013-205139 – volume: 56 start-page: 121 year: 2017 ident: R6 article-title: Both prolonged remission and lupus low disease activity state are associated with reduced damage accrual in systemic lupus erythematosus publication-title: Rheumatology doi: 10.1093/rheumatology/kew377 – volume: 58 start-page: 628 year: 2019 ident: R7 article-title: The relationship between remission and health-related quality of life in a cohort of SLE patients publication-title: Rheumatology doi: 10.1093/rheumatology/key349 – volume: 76 start-page: 2071 year: 2017 ident: R8 article-title: Remission and low disease activity status (LDAS) protect lupus patients from damage occurrence: data from a multiethnic, multinational Latin American lupus cohort (GLADEL) publication-title: Ann Rheum Dis doi: 10.1136/annrheumdis-2017-211814 – volume: 5 year: 2019 ident: R15 article-title: Time in remission and low disease activity state (LDAS) are associated with a better quality of life in patients with systemic lupus erythematosus: results from LUMINA (LXXIX), a multiethnic, multicentre US cohort publication-title: RMD Open doi: 10.1136/rmdopen-2019-000955 – volume: 22 start-page: 425 year: 2019 ident: R21 article-title: Development of the Asia Pacific lupus collaboration cohort publication-title: Int J Rheum Dis doi: 10.1111/1756-185X.13431 – volume: 28 start-page: 1344 year: 2019 ident: R11 article-title: Remission and low disease activity state prevent hospitalizations in systemic lupus erythematosus patients publication-title: Lupus doi: 10.1177/0961203319876998 – volume: 72 year: 2020 ident: R12 article-title: LLDAS (Low Lupus Disease Activity State) and Remission Prevent Damage Accrual in Systemic Lupus Erythematosus (SLE) Patients in a Primarily Mestizo Cohort [abstract] publication-title: Arthritis Rheumatol – volume: 72 year: 2020 ident: R9 article-title: Impact of Remission and Low Disease Activity Status on Hospitalizations Among SLE Patients from the GLADEL Latin American Cohort [abstract] publication-title: Arthritis Rheumatol – volume: 79 start-page: 943 year: 2020 ident: R20 article-title: Remission in systemic lupus erythematosus: testing different definitions in a large multicentre cohort publication-title: Ann Rheum Dis doi: 10.1136/annrheumdis-2020-217070 – volume: 76 start-page: 554 year: 2017 ident: R4 article-title: A framework for remission in SLE: consensus findings from a large international Task force on definitions of remission in SLE (DORIS) publication-title: Ann Rheum Dis doi: 10.1136/annrheumdis-2016-209519 – volume: 15 start-page: 180 year: 2019 ident: R1 article-title: Treat-to-target in rheumatoid arthritis - are we there yet? publication-title: Nat Rev Rheumatol doi: 10.1038/s41584-019-0170-5 – volume: 28 start-page: 423 year: 2019 ident: R14 article-title: Remission and low disease activity state (LDAS) are protective of intermediate and long-term outcomes in SLE patients. results from LUMINA (LXXVIII), a multiethnic, multicenter US cohort publication-title: Lupus doi: 10.1177/0961203319826693 – volume: 74 start-page: 2117 year: 2015 ident: R18 article-title: Prolonged remission in Caucasian patients with SLE: prevalence and outcomes publication-title: Ann Rheum Dis doi: 10.1136/annrheumdis-2015-207347 – volume: 45 start-page: 505 year: 2019 ident: R2 article-title: Treat to target in psoriatic arthritis publication-title: Rheum Dis Clin North Am doi: 10.1016/j.rdc.2019.07.002 – volume: 26 start-page: S69 year: 2020 ident: R13 article-title: Risk factors of remission and low disease Activitty state (LDAS) in systemic lupus erythematosus (SLE) patients. data from a multi-ethnic, multi-center US cohort publication-title: J Clin Rheumatol – volume: 76 start-page: 547 year: 2017 ident: R16 article-title: Remission in systemic lupus erythematosus: durable remission is rare publication-title: Ann Rheum Dis doi: 10.1136/annrheumdis-2016-209489 – volume: 76 start-page: 562 year: 2017 ident: R19 article-title: The effect of different durations of remission on damage accrual: results from a prospective monocentric cohort of Caucasian patients publication-title: Ann Rheum Dis doi: 10.1136/annrheumdis-2016-210154 – volume: 79 start-page: 1518 year: 2020 ident: R5 article-title: AB0448 IMPACT OF REMISSION ON DAMAGE ACCRUAL IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) PATIENTS: A SYSTEMATIC LITERATURE REVIEW (SLR) publication-title: Ann Rheum Dis doi: 10.1136/annrheumdis-2020-eular.2037 – volume: 70 start-page: 1790 year: 2018 ident: R17 article-title: Comparison of remission and lupus low disease activity state in damage prevention in a United States systemic lupus erythematosus cohort publication-title: Arthritis Rheumatol doi: 10.1002/art.40571 – volume: 72 start-page: 1159 year: 2020 ident: R10 article-title: Better health-related quality of life in systemic lupus erythematosus predicted by low disease activity State/Remission: data from the Peruvian Almenara lupus cohort publication-title: Arthritis Care Res doi: 10.1002/acr.24009 – ident: 2024052109573893000_8.1.e000538.1 doi: 10.1038/s41584-019-0170-5 – ident: 2024052109573893000_8.1.e000538.3 doi: 10.1136/annrheumdis-2013-205139 – ident: 2024052109573893000_8.1.e000538.15 doi: 10.1136/rmdopen-2019-000955 – ident: 2024052109573893000_8.1.e000538.12 – ident: 2024052109573893000_8.1.e000538.5 doi: 10.1136/annrheumdis-2020-eular.2507 – ident: 2024052109573893000_8.1.e000538.18 doi: 10.1136/annrheumdis-2015-207347 – ident: 2024052109573893000_8.1.e000538.4 doi: 10.1136/annrheumdis-2016-209519 – ident: 2024052109573893000_8.1.e000538.19 doi: 10.1136/annrheumdis-2016-210154 – volume: 58 start-page: 628 year: 2019 ident: 2024052109573893000_8.1.e000538.7 article-title: The relationship between remission and health-related quality of life in a cohort of SLE patients publication-title: Rheumatology doi: 10.1093/rheumatology/key349 – ident: 2024052109573893000_8.1.e000538.20 doi: 10.1136/annrheumdis-2020-217070 – volume: 28 start-page: 1344 year: 2019 ident: 2024052109573893000_8.1.e000538.11 article-title: Remission and low disease activity state prevent hospitalizations in systemic lupus erythematosus patients publication-title: Lupus doi: 10.1177/0961203319876998 – volume: 45 start-page: 505 year: 2019 ident: 2024052109573893000_8.1.e000538.2 article-title: Treat to target in psoriatic arthritis publication-title: Rheum Dis Clin North Am doi: 10.1016/j.rdc.2019.07.002 – ident: 2024052109573893000_8.1.e000538.8 doi: 10.1136/annrheumdis-2017-211814 – volume: 26 start-page: S69 year: 2020 ident: 2024052109573893000_8.1.e000538.13 article-title: Risk factors of remission and low disease Activitty state (LDAS) in systemic lupus erythematosus (SLE) patients. data from a multi-ethnic, multi-center US cohort publication-title: J Clin Rheumatol – volume: 72 start-page: 1159 year: 2020 ident: 2024052109573893000_8.1.e000538.10 article-title: Better health-related quality of life in systemic lupus erythematosus predicted by low disease activity State/Remission: data from the Peruvian Almenara lupus cohort publication-title: Arthritis Care Res doi: 10.1002/acr.24009 – ident: 2024052109573893000_8.1.e000538.16 doi: 10.1136/annrheumdis-2016-209489 – volume: 70 start-page: 1790 year: 2018 ident: 2024052109573893000_8.1.e000538.17 article-title: Comparison of remission and lupus low disease activity state in damage prevention in a United States systemic lupus erythematosus cohort publication-title: Arthritis Rheumatol doi: 10.1002/art.40571 – volume: 22 start-page: 425 year: 2019 ident: 2024052109573893000_8.1.e000538.21 article-title: Development of the Asia Pacific lupus collaboration cohort publication-title: Int J Rheum Dis doi: 10.1111/1756-185X.13431 – ident: 2024052109573893000_8.1.e000538.6 doi: 10.1093/rheumatology/kew377 – ident: 2024052109573893000_8.1.e000538.9 – volume: 28 start-page: 423 year: 2019 ident: 2024052109573893000_8.1.e000538.14 article-title: Remission and low disease activity state (LDAS) are protective of intermediate and long-term outcomes in SLE patients. results from LUMINA (LXXVIII), a multiethnic, multicenter US cohort publication-title: Lupus doi: 10.1177/0961203319826693 – reference: 35135871 - Lupus Sci Med. 2022 Feb;9(1): |
| SSID | ssj0001213780 |
| Score | 2.599038 |
| SecondaryResourceType | review_article |
| Snippet | ObjectiveTo achieve consensus on a definition of remission in SLE (DORIS).BackgroundRemission is the stated goal for both patient and caregiver, but consensus... To achieve consensus on a definition of remission in SLE (DORIS). Remission is the stated goal for both patient and caregiver, but consensus on a definition of... To achieve consensus on a definition of remission in SLE (DORIS).OBJECTIVETo achieve consensus on a definition of remission in SLE (DORIS).Remission is the... Objective To achieve consensus on a definition of remission in SLE (DORIS).Background Remission is the stated goal for both patient and caregiver, but... |
| SourceID | doaj pubmedcentral proquest pubmed crossref bmj |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | e000538 |
| SubjectTerms | Disease Epidemiology and Outcomes healthcare Humans Immunosuppressive Agents - therapeutic use lupus erythematosus Lupus Erythematosus, Systemic - drug therapy outcome assessment Patients Prednisolone - therapeutic use Quality of life Remission (Medicine) Remission Induction Serology Severity of Illness Index systemic Task forces therapeutics |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LT8MwDI4QB8QF8WYwUJAQB6SKpk3TlBuPIUA8JB4StypJEzHYOsS2_4-ddmNDCC5cGydNHFt24vgzIXsiYpqzggUqcjrgibFBVugwsKmKMl4YoWJMFL65FRdP_Oo5eZ4o9YVvwip44IpxhwZDljoDz5Y5LmSsbZQyy0AvLFOh9kigYPMmDlPV7QpQyFEYk8XisDN8H_ZBJiIW-ARUzEfR3dcpc-RR-39yNb-_mJwwQeeLZKH2HelxNeclMmPLZTJ3U0fHV4jC_9Kzu_vLB1pY1y79cyzac_QDq7rhvRhtl_ThunVEHVbDongc7nZtXVipTzHZhCqkmrgnpAPVf6Pg3Bq7Sp7OW4-nF0FdQiHQcFIYBJY7roswCznTxkkF_pYRqVMsVokxcagEeNfA3wI4nDjHnAoTl2kpnUs0pu2ukdmyV9oNQhWMwE1mZRI6Lo2SaQFbo6WAkUDtWYPsAz_zWgX6uT9dxCL3jM-RAXnF-AYJRyzPTQ1EjvUwOr91ORh3ea9QOH4jPsF9HBMigLb_AGKV12KV_yVWDdIcScHXkhB-DSy6FEmD7I6bYQMxyKJK2xt6GsT34UizXgnNeCaY9JzFEmaYTonT1FSnW8r2i8f8luBGwWo3_2NtW2Te64HPqGyS2cHH0G6DazXQO16LPgF1tB6o priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1dbxMxLIIhIV4mxmfHhoKEeECKdrnkcjle0AabBmIgMSb17ZTkklFY70qv_f_Yadq1CPX14uQcx04cO7YJea1ybiVvODN5sEwWzrOqsRnzpckr2ThlBAYKX3xV51fy87AYJoNbn55VLvfEuFE3nUMb-RGmvoLdVKvi_eQPw6pR6F1NJTTuknuYugyfdJXDcs3GwkWpl85MLtTRzXwy74Ezcs5iGCpGpdjxr41DKebu_5_C-e-7ybWD6Owh2U0aJD1eLPkeuePbR-T-RfKRPyYG_0s_fvv-6ZI2Poza-CiLdoFOsbYbWsfoqKWXX07f0YA1sSheisdjn8or9RRDTqhBqDVrIZ2Z_jcFFdf5J-Tq7PTHh3OWCikwC_eFGfMySNtkVSa5dUEb0LqcKoPhwhTOicwo0LF5bhtbiSIEHkxWhMpqHUJhMXj3Kdlpu9Y_J9TACNJVXhdZkNoZXTYSllsrGAmEnw_IG6BnnQShr-MdQ6g6Er5GAtQLwg9ItiR57VI6cqyKcbOty9tVl8kiF8c24BNcxxUgptGOH7rpdZ2ksnboD4dJg1ITpNLC-rzkHphGeW4yKwfkYMkFt1O65cQBebVqhgVEV4tpfTePMJjlRyLMswXTrDDB0OdKaMCw3GCnDVQ3W9rRz5j5W4MyBbPd347WC_IgcniMmDwgO7Pp3B-C6jSzL6N8_AVSXhdN priority: 102 providerName: ProQuest – databaseName: Scholars Portal Journals: Open Access dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3raxQxEB_aCqVfxHe3VokgfhBWN7vZbFYQ8dFSxVOwHvTbkmQTPXu3V-8B-t87k909e3IUv24mIZmZbH55zPwAHsuUG8FrHuvUm1jk1sVlbZLYFTotRW2lzihQePBJngzFh7P8bAt6eqtOgfONWzvikxrOxs9-_fz9Cif8y46R5Pl4ebGco7lTHofYUrUN13BhKmieDjq03x658KxQ_d3mxpp7sEuRqWVGTCzbZvJjbbkKWf03QdF_X1ReWqKOb8D1Dluy160z3IQt19yC3UF3e34bNHWBvfv85f0pq50fNeG5Fpt6NiPWNzo3Y6OGnX48esE8sWUx2i5PJq4jXpozCkZhmqQunSOyhZ6fMwS_1t2B4fHR17cncUexEBvcSSxiJ7wwdVImghvrlUY8ZmXhNc90bm2WaInom6emNmWWe8-9TnJfGqW8zw2F9d6FnWbauH1gGlsQtnQqT7xQVquiFugISmJL-FvgETxBfVa9hauw-8hkFWxQkQKq1gYRJL3KK9slKie-jPFVVZ6uqly0WTquEn5DdlwJUoLt8GE6-1Z187WydFOOg0a444VUmXFpwR36j3RcJ0ZEcNh7wd8hUXo2XPGVzCN4tCpGA9IljG7cdBlkKP-PIJl7rdOsetK7XgTFmjutdXW9pBl9DznBFcIsHO3B_yr5PuwFtw9RlYews5gt3QOEVwvzMEyaP-itH4M priority: 102 providerName: Scholars Portal |
| Title | 2021 DORIS definition of remission in SLE: final recommendations from an international task force |
| URI | https://lupus.bmj.com/content/8/1/e000538.full https://www.ncbi.nlm.nih.gov/pubmed/34819388 https://www.proquest.com/docview/2601801865 https://www.proquest.com/docview/2602635465 https://pubmed.ncbi.nlm.nih.gov/PMC8614136 https://doaj.org/article/c4212b93061f4683be271e1376e1a0b4 |
| Volume | 8 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjR1db9Mw8EQ3adoL4pvCqIyEeEDKGieO4_C2jU4D0YH2gcpTZDs2FGg69eP_c-ekpUVo4iWR4rNj353l-_DdAbySCTeCVzzSiTeRyKyLisrEkct1UojKSp1SoPDwXJ5diw-jbNQqik2pr5vl_NBMfjTxDJShqV70VZ_3XYgbVYdklu7ALhUmoStcxderDZsKT3O1cl7yVDbDISckPGq678MehZ4WKZVa6eB_ts6jkLb_X7Lm31cmN86g03twtxUe2VFD7ftwx9UPYG_YuscfgqYpsHefLt5fssr5cR3uY7GpZzMq60aGMTau2eXHwVvmqRwWI314MnFtZaU5o2gTpglqw1DIFnr-k6F0a90juD4dXJ2cRW0NhcigqrCInPDCVHERC26sVxoFLitzr3mqM2vTWEsUr3liKlOkmffc6zjzhVHK-8xQ3O5j2KmntXsKTOMIwhZOZbEXymqVVwIprSSOhPued-E14rNs98C8DOpFKstAg5IQUDY06EK8Qnlp20zkVBDj121d3qy73DRpOG4DPiY6rgEpg3b4MJ19K9sNWVpyheOiUZ7xQqrUuCTnDvlHOq5jI7pwsOKCP0ui_Gt4pCuZdeHluhkJSF4WXbvpMsBQgh9BME8aplnPZMV6Xci32Glrqtst9fh7SPqtUI7C1T77XyQ_h_3A9iFs8gB2FrOle4Hy08L0oJOP8l7YOj3YPToZDr_g-3hw_vmiF2wS-BwK9RvOKhru |
| linkProvider | BMJ Publishing Group Ltd |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELdGJwEviG8KA4wEPCBFixPHcZAQYqxTy9qC9iHtLbMdGwprWvohxD_F38idm3QtQn3ba3J2zuefL2ef746QlyJimrOCBSpyOuCJsUFW6DCwqYoyXhihYgwU7vVF-5R_OkvOtsifOhYGr1XWOtEr6mJk8Ix8F1NfgTaVInk__hlg1Sj0rtYlNBawOLS_f8GWbfqusw_z-yqKDlonH9tBVVUg0GA8zwLLHddFmIWcaeOkAhPEiNQpFqvEmDhUAgxOFulCZ3HiHHMqTFympXQu0RjJCv1eI9s8BoYaZHuv1f9ytHKqw-JU1u5TFovdi_l4PgUsRizwga8YB6OH39d-g75awP9M3H9vaq78-g5uk1uVzUo_LEB2h2zZ8i653qu88veIwu_S_c9HnWNaWDco_TUwOnJ0gtXk8DyODkp63G29pQ6rcFHchg-HtiroNKUY5EIVUq2cT9KZmv6gYFQbe5-cXomQH5BGOSrtI0IV9MBNZmUSOi6NkmnBAWBSQE-gbliTvAZ55tXSm-Z-VxOL3As-RwHkC8E3SViLPDdVAnSsw3GxqcmbZZPxIvvHJuI9nMclISbu9g9Gk695pQdygx54GDSYUY4LGWsbpcwCaIRlKtS8SXZqFFwO6RL7TfJi-RomEJ07qrSjuafBvEIcaR4uQLPkBIOts1gCh-kanNZYXX9TDr75XOMSzDcY7ePNbD0nN9onvW7e7fQPn5CbHu0-XnOHNGaTuX0KhttMP6tWCyXnV71A_wISIFZ6 |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELfGkCZeEN8UBhgJeECKGieO4yAhBHTVyj5AjEl9y2zHhsKalKYV4l_jr-POTboWob7tNTk79vnu8rPPd0fIMxExzVnBAhU5HfDE2CArdBjYVEUZL4xQMQYKHx2L_VP-YZgMt8ifNhYGr1W2NtEb6qIyeEbexdRXYE2lSLquuRbxqdd_M_kZYAUp9LS25TQWInJgf_-C7Vv9etCDtX4eRf29L-_3g6bCQKABSM8Cyx3XRZiFnGnjpAI4YkTqFItVYkwcKgHgk0W60FmcOMecChOXaSmdSzRGtUK_V8jVNE4Y6lg6TFfOd1icytaRymLRPZ9P5jVIZcQCHwKLETF6_H3th-jrBvwP7P57Z3PlJ9i_Qa436JW-XYjbTbJly1tk56jxz98mCr9Lex8_D05oYd2o9BfCaOXoFOvK4ckcHZX05HDvFXVYj4vihnw8tk1pp5piuAtVSLVyUklnqv5BAV4be4ecXgqL75LtsirtfUIV9MBNZmUSOi6NkmnBQdSkgJ7A8LAOeQH8zBslrHO_v4lF7hmfIwPyBeM7JGxZnpsmFTpW5Djf1OTlsslkkQdkE_E7XMclIabw9g-q6de8sQi5QV88TBoAleNCxtpGKbMgNMIyFWreIbutFFxM6UILOuTp8jUsILp5VGmruafBDEMcae4thGY5Egy7zmIJI0zXxGltqOtvytE3n3VcApCD2T7YPKwnZAfUMj8cHB88JNe8sPvAzV2yPZvO7SNAcDP92KsKJWeXrZt_AS8xWUo |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=2021+DORIS+definition+of+remission+in+SLE%3A+final+recommendations+from+an+international+task+force&rft.jtitle=Lupus+science+%26+medicine&rft.au=van+Vollenhoven%2C+Ronald+F&rft.au=Bertsias%2C+George&rft.au=Doria%2C+Andrea&rft.au=Isenberg%2C+David&rft.date=2021-11-01&rft.pub=Lupus+Foundation+of+America&rft.eissn=2053-8790&rft.volume=8&rft.issue=1&rft_id=info:doi/10.1136%2Flupus-2021-000538&rft_id=info%3Apmid%2F34819388&rft.externalDBID=lupus&rft.externalDocID=lupusscimed |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2053-8790&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2053-8790&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2053-8790&client=summon |